Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01993017 · ClinicalTrials.gov registry record · NA

Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
1,501
Enrollment target

NCT01993017: Completed NA study, sponsored by Columbia University.

NCT01993017 is a NA study that has completed, run by Columbia University. The registered enrollment target is 1,501 participants, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01993017, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
1,501 participants
Enrollment target

Study Summary

The purpose of this study is to examine, in a randomized controlled trial, the benefits and costs of the American Heart Association's (AHA) advisory for depression screen and treatment of post-acute coronary syndrome patients.

Primary Outcome

Change in QALYs from baseline through 18 months. QALYs are a generic measure of disease burden, including both the quality and the quantity of life lived. One QALY equates to one year in perfect health. To measure change in QALYs, utility scores \[an overall assessment of well-being on a scale from 0 (death) to 1 (perfect health)\], were estimated using the Short Form-6 dimension, with scores derived from responses to the 12-Item Short-Form Health Survey, version 2, at baseline and 6, 12, and 18

Interventions

  • OTHER No intervention
  • OTHER Standard Care
  • OTHER Cognitive Behavioral Therapy (CBT)
  • DRUG Antidepressant Medication
  • OTHER Depressive symptom screener

Trial Details

FieldValue
Enrollment Target 1,501 participants
Start Date 2013-11
Est. Completion 2019-07-31
Phase NA
Columbia University

958 total trials

What the finished NCT01993017 record still lists

NCT01993017 is an interventional study that assigns participants to a tested intervention. Its 1,501 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 1,404-participant average among 58,714 other NA trials with a reported enrollment target.

The record links to 0 conditions, and to 5 interventions - of which No intervention is the first listed.

NCT01993017 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01993017 about?

NCT01993017 is a clinical study titled "Comparison of Depression Identification After Acute Coronary Syndrome: Quality of Life and Cost Outcomes". The purpose of this study is to examine, in a randomized controlled trial, the benefits and costs of the American Heart Association's (AHA) advisory for depression screen and treatment of post-acute coronary syndrome patients.

What is the current status of trial NCT01993017?

This trial is currently completed. It is a NA study. The enrollment target is 1,501 participants. The study started on 2013-11. Estimated completion is 2019-07-31.

What interventions are being tested in trial NCT01993017?

The interventions under investigation include: No intervention (OTHER), Standard Care (OTHER), Cognitive Behavioral Therapy (CBT) (OTHER), Antidepressant Medication (DRUG), Depressive symptom screener (OTHER).

Who is sponsoring clinical trial NCT01993017?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01993017's enrollment target sits among peer trials

1,501 65th of 2000 higher than 1,936 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00178724 · 1,500 participants

    Spinal Cord Injury Registry - North American Clinical Trials Network

  • NCT00951366 · 1,500 participants

    Preterm Lung Patient Registry

  • NCT01050504 · 1,500 participants

    Collecting and Studying Blood and Tissue Samples From Patients With Locally Recurrent or Metastatic Prostate or Bladder/Urothelial Cancer

  • NCT02071134 · 1,500 participants

    Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01993017, the US trial registry maintained by the National Library of Medicine. NCT01993017 (large enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.